Home › Funds › MONTANOVA CAPITAL, LLC › CTNM
MONTANOVA CAPITAL, LLC position in CTNM
CONTINEUM THERAPEUTICS INC · Health Care
MONTANOVA CAPITAL, LLC reported holding 2,814,553 shares of CTNM (CONTINEUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$37.8M, representing 0.88% of its reported portfolio and ranking #32 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed CTNM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MONTANOVA CAPITAL, LLC's CTNM position evolved
MONTANOVA CAPITAL, LLC first disclosed a stake in CTNM in Q2 2024 at 2,053,334 shares (US$36.2M). The position peaked in Q2 2026 at 2,841,334 shares, worth US$46.6M. Across 10 filings, MONTANOVA CAPITAL, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,814,553 shares valued at US$37.8M — a reduction of -26,781 shares quarter over quarter.. Notable position changes include a 65% increase in Q4 2025 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 2.05M | $36.16M | New |
| Q3 2024 | 1.72M | $32.92M | Reduce |
| Q4 2024 | 1.72M | $25.20M | Hold |
| Q1 2025 | 1.72M | $12.01M | Hold |
| Q2 2025 | 1.72M | $6.83M | Hold |
| Q3 2025 | 1.72M | $20.21M | Hold |
| Q4 2025 | 2.84M | $32.48M | Add |
| Q1 2026 | 2.84M | $37.11M | Hold |
| Q2 2026 | 2.84M | $46.57M | Hold |
| Q3 2026 | 2.81M | $37.77M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CTNM and 13F data
CTNM (CONTINEUM THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in CTNM — the largest reported positions include JOHNSON & JOHNSON (US$26.6M), Trails Edge Capital Partners, LP (US$22.7M), Versant Venture Management, LLC (US$17.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CTNM
- JOHNSON & JOHNSON 1.98M sh · $26.56M · Q3 2026
- Trails Edge Capital Partners, LP 1.69M sh · $22.73M · Q3 2026
- Versant Venture Management, LLC 1.29M sh · $17.35M · Q3 2026
- Novo Holdings A/S 704.01K sh · $9.45M · Q3 2026
- SECTORAL ASSET MANAGEMENT INC 689.59K sh · $9.25M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 669.34K sh · $8.98M · Q3 2026
- Red Tree Management, LLC 638.16K sh · $8.56M · Q3 2026
- Boxer Capital Management, LLC 494.00K sh · $6.63M · Q3 2026
- Ikarian Capital, LLC 300.00K sh · $4.03M · Q3 2026
- Squadron Capital Management LLC 225.00K sh · $3.02M · Q3 2026
- Palo Alto Investors LP 220.23K sh · $2.96M · Q3 2026
- HighVista Strategies LLC 217.79K sh · $2.92M · Q3 2026
More on MONTANOVA CAPITAL, LLC
FAQ
How long has MONTANOVA CAPITAL, LLC held CTNM?
MONTANOVA CAPITAL, LLC has disclosed CTNM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is MONTANOVA CAPITAL, LLC's current position in CTNM?
As of Q3 2026, MONTANOVA CAPITAL, LLC holds 2.81M shares of CTNM (CONTINEUM THERAPEUTICS INC), valued at $37.77M, representing 0.88% of its reported portfolio and ranking #32.
Has MONTANOVA CAPITAL, LLC been buying or selling CTNM?
In the latest 13F filing (Q3 2026), MONTANOVA CAPITAL, LLC reduced its position in CTNM. The position peaked in Q2 2026 at 2.84M shares.
Which other funds hold CTNM?
Other major institutional holders of CTNM include JOHNSON & JOHNSON, Trails Edge Capital Partners, LP, Versant Venture Management, LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.